|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/62 | |
| C07K 19/00 | |||
| C07K 16/24 | |||
| C12N 15/85 | |||
| A61K 35/17 |
| (11) | Patento numeris | 3333264 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16833374.8 |
| Europos patento paraiškos padavimo data | 2016-08-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2016/008632 |
| Data | 2016-08-05 |
| (87) | Numeris | WO 2017/023138 |
| Data | 2017-02-09 |
| (30) | Numeris | Data | Šalis |
| 20150110788 | 2015-08-05 | KR |
| (72) |
KONG, Seogkyoung, KR
|
| (73) |
CellabMED Inc.,
No 1301-1, 38-21, Digital-ro 31-gil, Guro-gu, Seoul,
KR
|
| (54) | CHIMERIC ANTIGEN RECEPTOR, AND T CELLS IN WHICH CHIMERIC ANTIGEN RECEPTOR IS EXPRESSED |
| CHIMERIC ANTIGEN RECEPTOR, AND T CELLS IN WHICH CHIMERIC ANTIGEN RECEPTOR IS EXPRESSED |